As of 1:16pm ET
| +0.0068 / +1.51%|
The 2 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 1.95, with a high estimate of 3.00 and a low estimate of 0.90. The median estimate represents a +326.23% increase from the last price of 0.46.
The current consensus among 2 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.